tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO
US Market
Advertisement

Halozyme (HALO) Technical Analysis

Compare
1,095 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is -1.70, suggesting Halozyme Therapeutics is a Buy.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 68.50, while Halozyme Therapeutics’s (HALO) share price is $66.88, making it a Sell.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 68.77, while Halozyme Therapeutics’s (HALO) share price is $66.88, making it a Sell.

Halozyme (HALO) Pivot Points

Oct 23, 2025, 02:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
63.19
64.17
65.32
66.29
67.44
68.42
69.57
Fibonacci
64.17
64.98
65.48
66.29
67.10
67.60
68.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Oct 23, 2025, 02:23 AM
Period
Simple
Exponential
MA5
66.72Buy
66.66Buy
MA10
66.00Buy
67.02Sell
MA20
68.93Sell
68.50Sell
MA50
71.51Sell
68.77Sell
MA100
63.86Buy
65.89Buy
MA200
61.13Buy
61.91Buy
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 67.02, while Halozyme Therapeutics’s (HALO) share price is $66.88, making it a Sell.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 65.89, while Halozyme Therapeutics’s (HALO) share price is $66.88, making it a Buy.
Halozyme Therapeutics’s (HALO) stock price is $66.88 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 71.51, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $66.88 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 63.86, creating a Buy signal.
Halozyme Therapeutics’s (HALO) stock price is $66.88 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 61.13, creating a Buy signal.

Halozyme (HALO) Technical Indicators

Oct 23, 2025, 02:23 AM
Name
Value
Implied Action
RSI (14)
40.30
Neutral
STOCH (9,6)
71.41
Neutral
STOCHRSI (14)
24.63
Neutral
MACD (12,26)
-1.70
Buy
ADX (14)
31.34
Neutral
Williams %R
-73.55
Buy
CCI (14)
-45.54
Neutral
ATR (14)
2.01
-
Ultimate Oscillator
54.27
Neutral
ROC
-10.76
Sell
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 40.30, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 31.34, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is -45.54, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is -10.76, creating a Sell signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Hold.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 40.30, which suggests HALO is a Neutral.
      What is HALO’s MACD?
      HALO’s MACD is -1.70, which suggests HALO is a Buy.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 66.72, which suggests HALO is a Buy.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 68.93, which suggests HALO is a Sell.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 71.51, which suggests HALO is a Sell.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 61.13, which suggests HALO is a Buy.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -73.55, which suggests HALO is a Buy.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is -45.54, which suggests HALO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis